Virax Biolabs Group Limited () SEC Filings https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/rss Virax Biolabs Group Limited () - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/viraxbiolabs/files/theme/images/logo-300px.png Virax Biolabs Group Limited Logo Equisolve Investor Relations Suite <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-153963/0001193125-26-153963.pdf Tue, 14 Apr 26 08:44:24 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-153963/0001193125-26-153963.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-151292/0001193125-26-151292.pdf Fri, 10 Apr 26 16:15:23 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-151292/0001193125-26-151292.pdf <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-134281/0001193125-26-134281.pdf Tue, 31 Mar 26 15:15:30 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-134281/0001193125-26-134281.pdf <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950130-26-000117/0000950130-26-000117.pdf Fri, 20 Mar 26 10:43:42 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950130-26-000117/0000950130-26-000117.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-114283/0001193125-26-114283.pdf Wed, 18 Mar 26 17:11:27 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-114283/0001193125-26-114283.pdf <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-113908/0001193125-26-113908.pdf Wed, 18 Mar 26 16:06:09 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-113908/0001193125-26-113908.pdf <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-113909/0001193125-26-113909.pdf Wed, 18 Mar 26 16:05:56 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-113909/0001193125-26-113909.pdf <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-113905/0001193125-26-113905.pdf Wed, 18 Mar 26 16:05:51 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-113905/0001193125-26-113905.pdf <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-113915/0001193125-26-113915.pdf Wed, 18 Mar 26 16:05:46 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-113915/0001193125-26-113915.pdf <![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001172661-26-001233/0001172661-26-001233.pdf Tue, 14 Apr 26 14:00:56 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001172661-26-001233/0001172661-26-001233.pdf